首页> 外国专利> Enhanced generation of cytotoxic T lymphocytes by IL-21 mediated FoxP3 suppression

Enhanced generation of cytotoxic T lymphocytes by IL-21 mediated FoxP3 suppression

机译:IL-21介导的FoxP3抑制作用增强细胞毒性T淋巴细胞的产生

摘要

A method of carrying out adoptive immunotherapy by administering a subject an antigen-specific cytotoxic T lymphocytes (CTL) preparation in a treatment-effective amount is described. In the method, the CTL preparation is preferably administered as a preparation of an in vitro antigen-stimulated and expanded primate CTL population, the CTL population: (i) depleted of FoxP3+ T lymphocytes prior to antigen stimulation; (ii) antigen-stimulated in vitro in the presence of interleukin-21; or (iii) both depleted of FoxP3+ T lymphocytes prior to antigen stimulation and then antigen-stimulated in vitro in the presence of interleukin-21. Methods of preparing such compositions, and compositions useful for carrying out the adoptive immunotherapy, are also described.
机译:描述了通过以治疗有效量向受试者施用抗原特异性细胞毒性T淋巴细胞(CTL)制剂来进行过继免疫疗法的方法。在该方法中,CTL制剂优选作为体外抗原刺激的和扩增的灵长类CTL种群的制剂施用,所述CTL种群:(i)在抗原刺激之前耗尽FoxP3 + T淋巴细胞; (ii)在白介素21存在下体外刺激抗原;或(iii)在抗原刺激之前先清除FoxP3 + T淋巴细胞,然后在白介素21的存在下在体外进行抗原刺激。还描述了制备此类组合物的方法以及可用于进行过继免疫疗法的组合物。

著录项

  • 公开/公告号US10072246B2

    专利类型

  • 公开/公告日2018-09-11

    原文格式PDF

  • 申请/专利权人 THE FRED HUTCHINSON CANCER RESEARCH CENTER;

    申请/专利号US201615188096

  • 发明设计人 CASSIAN YEE;YONGQING LI;

    申请日2016-06-21

  • 分类号C12N5/0783;A61K31/41;A61K39;A61K35/17;A61K35/12;

  • 国家 US

  • 入库时间 2022-08-21 13:06:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号